- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16:50 | ADDvise Group AB (publ): ADDvise announces financial update for 2025 | 47 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all their... ► Artikel lesen | |
| 05.01. | ADDvise Group AB (publ): Statement from the independent bid committee of ADDvise in relation to the public offer from Amplex | 112 | GlobeNewswire (Europe) | The independent bid committee of ADDvise recommends that holders of shares and warrants who have a short-term perspective on their ownership or who do not wish to be owners in a listed ADDvise with... ► Artikel lesen | |
| 02.01. | ADDvise Group AB (publ): ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex | 261 | GlobeNewswire (Europe) | ADDvise Group AB (publ) (the "Company" or "ADDvise") has instructed the agent under the Company's outstanding bonds 2025/2028 with ISIN SE0025011885 (the "Bonds") to initiate a written procedure in... ► Artikel lesen | |
| 30.12.25 | AMPLEX AB: Amplex enters into additional agreements on conditional acquisitions of shares and warrants in ADDvise | 2 | Cision News | ||
| 19.12.25 | ADDvise Group AB (publ): Amplex has increased the consideration in the public offer to the shareholders and warrant holders of ADDVise | 67 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all shares... ► Artikel lesen | |
| 19.12.25 | Amplex AB publishes supplement to the offer document regarding the cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 1 | Cision News | ||
| 19.12.25 | AMPLEX AB: Amplex increases the consideration in the cash offer to the shareholders and warrantholders of ADDvise and enters into agreements on conditional acquisitions of shares and warrants in ADDvise | 3 | Cision News | ||
| ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
| 10.12.25 | ADDvise Group AB (publ) receives observation status | 299 | GlobeNewswire | Today, December 10, 2025, Amplex AB disclosed a public offer to the other shareholders and equity rights holders of ADDvise Group AB (publ).
The rules of Nasdaq First North Growth Market state... ► Artikel lesen | |
| 10.12.25 | AMPLEX AB: Amplex publishes the offer document for the public cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 4 | Cision News | ||
| 10.12.25 | Amplex AB announces a cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 7 | Cision News | ||
| 10.12.25 | ADDvise Group AB (publ): ADDvise's board of directors evaluates the public offer from Amplex | 150 | GlobeNewswire (Europe) | Amplex AB ("Amplex") has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise") to transfer all shares and warrants in ADDvise to Amplex at a price... ► Artikel lesen | |
| 12.11.25 | ADDvise Group AB (publ): ADDvise receives order worth USD 2.3 million | 145 | GlobeNewswire (Europe) | ADDvise Group's subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3... ► Artikel lesen | |
| 23.10.25 | ADDvise Group AB (publ): Interim report 2025, January 1-September 30 | 136 | GlobeNewswire (Europe) | Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive.... ► Artikel lesen | |
| 17.07.25 | ADDvise Group AB (publ): Interim report 2025, January 1-June 30 | 166 | GlobeNewswire (Europe) | In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow... ► Artikel lesen | |
| 26.05.25 | ADDvise Group AB (publ): ADDvise enters into facilities agreement with Nordea - reduces financial costs by approximately SEK 56 million per year | 1.590 | GlobeNewswire (Europe) | ADDvise Group AB (publ) has entered into a new secured facilities agreement with Nordea Bank Abp, filial i Sverige, with a total limit of SEK 450 million. As previously communicated, the company will... ► Artikel lesen | |
| 12.05.25 | ADDvise Group AB (publ): Johan Irwe is appointed CFO, Staffan Torstensson (also CEO) assumes role as Head of the Healthcare segment, and Fredrik Mella departs | 166 | GlobeNewswire (Europe) | Since July 2024, Johan Irwe has served as interim CFO and has delivered strong results in the role. With his sharp analytical skills and dedicated leadership, Johan has created significant value for... ► Artikel lesen | |
| 12.05.25 | ADDvise Group AB (publ): Report from the annual general meeting of ADDvise Group AB (publ) on 12 May 2025 | 175 | GlobeNewswire (Europe) | ADDvise Group AB (publ), reg. no. 556363-2115, has today, on 12 May 2025, held its annual general meeting at the company's premises at Grev Turegatan 30 in Stockholm. At the meeting it was resolved... ► Artikel lesen | |
| 09.05.25 | ADDvise Group AB (publ): Interim report 2025, January 1-March 31 | 183 | GlobeNewswire (Europe) | In the first quarter of 2025, net revenue increased organically with continued good profitability, which shows stable demand in medical technology and laboratory solutions. Cash flow from operating... ► Artikel lesen | |
| 24.04.25 | New equity right for trading, ADDvise Group AB | 251 | GlobeNewswire | At the request of ADDvise Group AB, equity rights will be traded on First North Growth Market as from 25 April 2025.
Security name:
ADDvise Group AB TO 1 A
Short... ► Artikel lesen | |
| 18.03.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.03.2025 | 744 | Xetra Newsboard | Das Instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE EO -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.03.2025 und ex Kapitalmassnahme am 19.03.2025 The instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 36,970 | -6,02 % | Fresenius Medical Care startet zweite Aktienrückkauftranche am 12. Januar | DJ Fresenius Medical Care startet zweite Aktienrückkauftranche am 12. Januar
DOW JONES--Fresenius Medical Care beginnt am Montag mit der zweiten von zwei Tranchen des geplanten Aktienrückkaufs... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,050 | +0,66 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers auf "Outperform" mit einem Kursziel von 52,90 Euro belassen. 2025 sei ein schlechtes Jahr... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,100 | -2,67 % | Bechtle, Carl Zeiss Meditec, CTS Eventim, MTU Aero Engines, Suss MicroTec, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| UNITEDHEALTH | 290,00 | +1,13 % | Washington ermittelt: Wenn Krankheiten zum Geschäft werden: UnitedHealth unter Druck | © Foto: SOPA Images - Sipa USAEin Senatsbericht wirft UnitedHealth aggressive Methoden bei Medicare Advantage vor. Interne Vorgaben, fragliche Diagnosen und Milliarden an Extra-Zahlungen stehen im Raum.Die... ► Artikel lesen | |
| MEDTRONIC | 84,33 | +1,81 % | Medtronic Receives FDA Clearance For MiniMed Go Smart MDI Diabetes App | WASHINGTON (dpa-AFX) - Medtronic (MDT), a medical device company, on Monday announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its MiniMed Go app. This... ► Artikel lesen | |
| INTUITIVE SURGICAL | 468,55 | -2,88 % | Intuitive Surgical, Inc.: Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results | SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today... ► Artikel lesen | |
| THERMO FISHER | 533,40 | +2,36 % | EQS-News: TetraScience kündigt Zusammenarbeit mit Thermo Fisher Scientific an, um wissenschaftliche Daten und KI-Fähigkeiten im Labor zu beschleunigen | EQS-News: TetraScience
/ Schlagwort(e): Vertrag
TetraScience kündigt Zusammenarbeit mit Thermo Fisher Scientific an, um wissenschaftliche Daten und KI-Fähigkeiten im Labor zu... ► Artikel lesen | |
| TELADOC HEALTH | 5,678 | -5,48 % | Teladoc Health Unveils New Capabilities to Treat More Conditions and Detect Care Gaps Earlier | ||
| HIMS & HERS HEALTH | 26,910 | -2,68 % | 4 Analysts Have This To Say About Hims & Hers Health | ||
| BICO GROUP | 1,780 | -1,22 % | BICO Group AB: Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB | BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.
Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 72,04 | -1,34 % | Eurofins: Weekly Report on Share Repurchases From 05th January to 09th January 2026 | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily... ► Artikel lesen | |
| BECTON DICKINSON | 177,50 | +2,57 % | BD Invests $110 Mln To Expand Prefillable Syringe Production, To Add Around 120 New Jobs | WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX), a medical technology company, Tuesday announced that it is investing $110 million to expand its production of prefillable syringes... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 147,05 | +0,58 % | Here's What to Expect From Align Technology's Next Earnings Report | ||
| NUGEN MEDICAL DEVICES | 0,018 | -11,11 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| INMODE | 11,970 | -0,66 % | InMode Q4 Preliminary Revenue Rises |
ADDVISE GROUP AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,134 Euro. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADDVISE GROUP AB finden Sie auf Wallstreet Online.